Amanote Research
Register
Sign In
VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor Growth
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-0384
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
August 1, 2005
Authors
W. Hou
Publisher
American Association for Cancer Research (AACR)
Related search
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
Clinical Cancer Research
Cancer Research
Oncology
Transthyretin Stimulates Tumor Growth Through Regulation of Tumor, Immune, and Endothelial Cells
Journal of Immunology
Allergy
Immunology
Tumor-Induced Endothelial Cell Activation: Role of Vascular Endothelial Growth Factor
American Journal of Physiology - Cell Physiology
Physiology
Cell Biology
PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth
PLoS ONE
Multidisciplinary
Phloroglucinol Inhibits the Bioactivities of Endothelial Progenitor Cells and Suppresses Tumor Angiogenesis in LLC-Tumor-Bearing Mice
PLoS ONE
Multidisciplinary
BCL-2 Orchestrates a Cross-Talk Between Endothelial and Tumor Cells That Promotes Tumor Growth
Cancer Research
Cancer Research
Oncology
MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1
Frontiers in Genetics
Genetics
Molecular Medicine
Vascular Endothelial Growth Factor Receptor-2-Mediated Mitogenesis Is Negatively Regulated by Vascular Endothelial Growth Factor Receptor-1 in Tumor Epithelial Cells
American Journal of Pathology
Forensic Medicine
Pathology
Correction: Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1
Cancer Research
Cancer Research
Oncology
